Cytokinetics stock price

Are you tired of spending endless hours searching for high-quality stock photos only to discover that they come with a hefty price tag? Look no further. In this article, we will ex...

Find the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing.Cytokinetics’ share price fell 16% yesterday on news that Novartis has dropped its pursuit of the biotech. ... One problem for potential buyers is the phase 3 data sent the stock into overdrive.What this means: Cytokinetics (CYTK) gets an Overall Rank of 69, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. View Cytokinetics (NASDAQ:CYTK) historical prices, past price performance, and an advanced CYTK stock chart at MarketBeat.Apellis Pharmaceuticals Inc. 68.78. +1.20. +1.78%. Get Cytokinetics Inc (CYTK:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Cytokinetics (CYTK) Stock Price Performance. Cytokinetics (CYTK) Stock Key Data. ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months. What this means: Cytokinetics (CYTK) gets an Overall Rank of 69, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value.

Stock Chart; Historical Price Lookup; Data Provided by Refinitiv. Minimum 15 minutes delayed. More Resources. Site - Investor Relations. Stock Information. ... (e.g., manuscripts, posters and/or oral presentations that contain data from Cytokinetics-sponsored studies, have Cytokinetics authors, or for which Cytokinetics provides …3 days ago · Summary of all time highs, changes and price drops for Cytokinetics; Historical stock prices; Current Share Price: US$75.59: 52 Week High: US$110.25: 52 Week Low: US ... Cytokinetics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CYTK stock price.CYTK: Lowering target price to $30.00. (Argus Research) Apr-20-23 04:00PM. Cytokinetics to Announce First Quarter Results on May 4, 2023. (GlobeNewswire) Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people ... CYTK stock tacked on another 15%-plus on Jan. 8 when a rumor suggested Novartis could be entertaining a buyout bid for Cytokinetics. That put CYTK stock's gain at more than 141% over two weeks. Cytokinetics Inc stock is currently priced at $76.89, with a 24-hour trading volume of 1.32M. It has seen a -2.13% decreased in the last 24 hours and a -5.30% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $77.77 pivot point. If it approaches the $76.83 support level, significant changes may ...

Cytokinetics (CYTK) reports positive results from its pivotal late-stage study of aficamten in symptomatic obstructive hypertrophic cardiomyopathy patients. The stock rallies 83% in response.Corporate Presentation. Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. Shares of Cytokinetics, ... Stock Market News, Jan. 8, 2024: S&P 500 Rebounds, Boosted by the Magnificent Seven Boeing shares fell, weighing on the Dow industrials; Nvidia climbs.CYTK stock tacked on another 15%-plus on Jan. 8 when a rumor suggested Novartis could be entertaining a buyout bid for Cytokinetics. That put CYTK stock's gain at more than 141% over two weeks.

Song of the south lyrics.

Apellis Pharmaceuticals Inc. 68.78. +1.20. +1.78%. Get Cytokinetics Inc (CYTK:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.Cytokinetics Inc stock price (CYTK) NASDAQ: CYTK. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Cytokinetics Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock.Cytokinetics Inc stock price (CYTK) NASDAQ: CYTK. Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Cytokinetics Inc stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock.Cytokinetics Stock Earnings. The value each CYTK share was expected to gain vs. the value that each CYTK share actually gained. Cytokinetics ( CYTK) reported Q3 2023 earnings per share (EPS) of -$1.35, missing estimates of -$0.74 by 81.36%. In the same quarter last year, Cytokinetics 's earnings per share (EPS) was -$1.52. Check the Cytokinetics stock price today on the NASDAQ stock exchange and access historical CYTK stock price chart. Get the latest Cytokinetics stock ...

Cytokinetics Inc. historical stock charts and prices, analyst ratings, financials, and today’s real-time CYTK stock price.Stock Chart; Historical Price Lookup; Change. Volume. Today's Open. Previous Close. Today's High. Today's Low. 52 Week High. 52 Week Low. Data Provided by ... (e.g., manuscripts, posters and/or oral presentations that contain data from Cytokinetics-sponsored studies, have Cytokinetics authors, or for which Cytokinetics provides …Dec 31, 2022. -299,516. -296,741. Item. Description. The company. FCFF. Free cash flow to the firm is the cash flow available to the Cytokinetics Inc. suppliers of capital after all operating expenses have been paid and necessary investments in working and fixed capital have been made. Cytokinetics Inc. FCFF decreased from 2020 to 2021 and from ...Cytokinetics to Announce Fourth Quarter Results on February 27, 2024. Globe Newswire • 10 days ago. Track Cytokinetics Inc (CYTK) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors.Maintaining a Buy rating and a price target of $50, Choi concludes that Cytokinetics represents an attractive investment opportunity based on the upcoming catalysts and its long-term market potential.View Cytokinetics (CYTK) stock price, news, historical charts, analyst ratings, financial information and quotes on Moomoo. Trade commission-free with the ...Research Cytokinetics' (Nasdaq:CYTK) stock key valuation metrics while comparing it with its industry peers & market side by side. Research ... The above table shows the analyst CYTK forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current ...Maintaining a Buy rating and a price target of $50, Choi concludes that Cytokinetics represents an attractive investment opportunity based on the upcoming catalysts and its long-term market potential.

Feb 13, 2024 · Analyst Salim Syed of Mizuho Securities maintained a Buy rating on Cytokinetics (CYTK – Research Report), with a price target of $103.00. Salim Syed has given his Buy rating due to a combination ...

Cytokinetics is collaborating with Amgen Inc. to develop omecamtiv mecarbil, a novel cardiac muscle activator, for the potential treatment of heart failure, and with Astellas Pharma Inc. to develop CK-2127107, a fast skeletal muscle activator, for the potential treatment of spinal muscular atrophy. Stock split history for Cytokinetics since 2004.Cytokinetics Stock Performance (As of Tuesday Closing) Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS; $84.80: $83.69: $25.98 - $110.25: $8.31B: 98.1M: 3.63M-$5.52: Cytokinetics Financials Summary. In Thousands, USD TTM 30-Sep-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021In another report released on October 30, J.P. Morgan also maintained a Buy rating on the stock with a $48.00 price target. ... Cytokinetics price target lowered to $48 from $54 at JPMorgan;View CYTK price history, and other historical data. Get the latest Cytokinetics Inc (CYTK) stock price, news, analysis, and research in Stockscan.io.If you want to keep up to date on the stock market you have a device in your pocket that makes that possible. Your phone can track everything finance-related and help keep you up t...By Ben Glickman. Shares of Cytokinetics jumped Monday after the Wall Street Journal reported the company was close to being bought by Novartis. The stock was up 16% to $109.22 after the news broke ...Use our equities screener to discover other potential opportunities. Find Similar Stocks Find Stocks Similar to CYTK ... Employees, Price/earnings (TTM), Price/ ...B. Riley started coverage on Cytokinetics in a research report on Tuesday, November 7th. They set a "buy" rating and a $66.00 target price on the stock. UBS …Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, includi...

Ms swan.

Download sketchup sketchup.

Cytokinetics (CYTK) Stock Price Performance. Cytokinetics (CYTK) Stock Key Data. ... Consensus Price Target is the stock price analysts expect to see within a period of 0-18 months. Find the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing. Find the historical stock prices of Cytokinetics (CYTK)Stock price history for Cytokinetics (CYTK) Highest end of day price: $108.06 USD on 2024-01-08. Lowest end of day price: $3.07 USD on 2014-10-10. Stock price history of Cytokinetics from 2004 to 2024. Stock price for similar companies or competitors. Company Stock price Change 1d% Country; Amgen. AMGN. $294.43: …With Cytokinetics stock trading at $84.12 per share, the total value of Cytokinetics stock (market capitalization) is $8.25B. Cytokinetics stock was originally …Spruce Biosciences Inc. $5.09 $0.03 (0.59%) Thinking about buying or selling stock in CYTK? See the latest Cytokinetics (CYTK) stock analysis, price, forecast, news and more.Related news How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month. 2/09/2024 Cytokinetics has shucked off two high-profile setbacks, leading CYTK stock to double as it ...With stocks at historic highs, many individuals are wondering if the time is right to make their first foray in the stock market. The truth is, there is a high number of great stoc...Stock Chart; Historical Price Lookup; Data Provided by Refinitiv. Minimum 15 minutes delayed. More Resources. Site - Investor Relations. Stock Information. ... (e.g., manuscripts, posters and/or oral presentations that contain data from Cytokinetics-sponsored studies, have Cytokinetics authors, or for which Cytokinetics provides … ….

How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month. Cytokinetics has shucked off two high-profile setbacks, leading CYTK stock to double as it looks to take on Bristol in heart disease.In another report released on October 30, J.P. Morgan also maintained a Buy rating on the stock with a $48.00 price target. ... Cytokinetics price target lowered to $48 from $54 at JPMorgan;View live Cytokinetics, Incorporated chart to track its stock's price action. Find market predictions, CYTK financials and market news. Real time Cytokinetics (CYTK) stock price quote, stock graph, news & analysis. Buy Rating for Cytokinetics Supported by Strong Trial Results and ... B.Riley Financial also maintained a Buy rating on the stock with a $122.00 price target. See the top stocks recommended by ...5 days ago · According to the issued ratings of 16 analysts in the last year, the consensus rating for Cytokinetics stock is Moderate Buy based on the current 3 hold ratings and 13 buy ratings for CYTK. The average twelve-month price prediction for Cytokinetics is $73.94 with a high price target of $108.00 and a low price target of $42.00. 5 days ago · Date Requested Open Price Day High Day Low Closing Price Volume Split Adjustment Factor; February 20, 2024: $76.62: $78.00: $76.01: $76.89: 1,136,377: 1:1: February ... On average, Wall Street analysts predict. that Cytokinetics's share price could reach $83.36 by Jan 24, 2025. The average Cytokinetics stock price prediction forecasts a potential upside of 8.42% from the current CYTK share price of $76.89. Cytokinetics Inc stock is currently priced at $76.89, with a 24-hour trading volume of 1.32M. It has seen a -2.13% decreased in the last 24 hours and a -5.30% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $77.77 pivot point. If it approaches the $76.83 support level, significant changes may ...CYTK, Cytokinetics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines RESEARCH. Shopping Cart. Your ... How Cytokinetics Overcame Two Setbacks And Doubled Its Stock Price Over A Month Investor's Business Daily 02/09/2024 10:01 AM ET. Dow Jones ... Cytokinetics stock price, [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1], [text-1-1]